Abstract PS5-01-08: Development of the HER2DX Predictor of Brain Metastasis in Advanced HER2-Positive Breast Cancer Treated with First-Line THP
Rodrigo Sánchez-Bayona(Research Institute Hospital 12 de Octubre), M. Jarzab(The Maria Sklodowska-Curie National Research Institute of Oncology), Marcin Kubeczko(The Maria Sklodowska-Curie National Research Institute of Oncology), Jesús Soberino(Hospital Quirónsalud Barcelona), Bartłomiej Pyciński(Silesian Center for Heart Disease), Isabel García-Fructuoso(Breast Cancer Research Foundation), A. Prat(Cancer Clinic), Ewa Chmielik(National Institute of Oncology), Malgorzata Oczko-Wojciechowska(National Institute of Oncology), L. Pare(Oryzon Genomics (Spain)), M. Rey(Fundació Clínic per a la Recerca Biomèdica), M. Gonzalez(Hospital Clínic de Barcelona), F. Pardo(Oryzon Genomics (Spain)), I. Monge(Hospital Clínic de Barcelona), J. Montes(Research Institute Hospital 12 de Octubre), F. Schettini(Hospital Clínic de Barcelona), A. Lesniak(The Maria Sklodowska-Curie National Research Institute of Oncology), G. Villacampa(Genomics Medicine (Ireland)), P. Galván(Fundació Clínic per a la Recerca Biomèdica), F. Brasó-Maristany(Fundació Clínic per a la Recerca Biomèdica), T. Pascual(Hospital Clínic de Barcelona), Valeria Sirenko(Breast Cancer Research Foundation), E. Ciruelos(Research Institute Hospital 12 de Octubre), Sandra Cobo(Breast Cancer Research Foundation)
Cited by 0
Related Papers
Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
|Cancer Discovery|2020|183
Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry
|British Journal of Cancer|2017|106
Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Early Breast Cancer
|JAMA Oncology|2024|77
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer
|Nature Communications|2023|65
Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry
|European Journal of Surgical Oncology|2018|60